Eli Lilly walks diabetes tightrope as Novo Nordisk shortages drive demand for Trulicity and Mounjaro In wake of bempeg blowup, Sanofi rethinks $2.5B bet on IL-2 after midphase efficacy falls short After Adderall, common antibiotic amoxicillin runs into shortage amid demand spikes and manufacturing woes UPDATE: Lilly powers through final stretch in critical Alzheimer's race Gilead continues to peg hopes of cancer business growth on Trodelvy momentum Eisai's Alzheimer's hopeful lecanemab may have contributed to patient death: report AbbVie expects Skyrizi, Rinvoq to eclipse Humira's sales peak, CEO Gonzalez says ResMed banks on smoother supply chain in 2023 to meet demand from Philips' CPAP recall EMA cracks down on JAK inflammatory disease drugs, limiting AbbVie's Rinvoq and more on safety risks Drug that acts on brain's dorsal raphe nucleus could rapidly treat depression | 